Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Tuesday, January 22, 2019 · 474,376,267 Articles · 3+ Million Readers

Marc J Bern & Partners LLP Files Lawsuits For A Hundred Individuals Against Merck Alleging Zostavax Vaccine is Defective

MARC J. BERN & PARTNERS LLP FILES LAWSUITS FOR A HUNDRED INDIVIDUALS AGAINST MERCK ALLEGING SHINGLES/ZOSTAVAX VACCINE IS DEFECTIVE*

NEW YORK, NEW YORK, UNITED STATES , April 21, 2017 /EINPresswire.com/ -- MARC J. BERN & PARTNERS LLP FILES LAWSUITS FOR A HUNDRED INDIVIDUALS AGAINST MERCK ALLEGING SHINGLES/ZOSTAVAX VACCINE
IS DEFECTIVE*

MARC J. BERN & PARTNERS LLP, the attorneys who last month filed their first complaint in Philadelphia Court of Common Pleas on behalf of Jorja Bently, today have filed complaints for another 100 plaintiffs against Merck regarding its Shingles vaccine, Zostavax. The assertions are wide ranging and include plaintiffs claiming to have suffered various side effects which include contracting shingles, chickenpox, high blood pressure, intense neuropathic pain, eye injuries, headaches, dizziness amongst others.

It is alleged by Marc J. Bern & Partners LLP that “Merck knew and had reason to know that its Zostavax vaccine was inherently defective and unreasonably dangerous as designed” that “Merck downplayed the serious and dangerous side effects of its product to encourage sales of the product; consequently, Merck placed its profits above its customers’ safety.” According to founding Partner Marc J Bern, the firm is currently representing nearly 5000 claimants and has thousands more filings to follow. “We have been investigating this drug for quite some time. We steadfastly believe in the merits of this litigation. This vaccination is at best 50 percent effective. Either it is not effective or it causes shingles or a host of other side effects. What is most troubling is that Merck had a better alternative on hand when this product was released.” says Bern.

About Marc J Bern

Mr. Bern has been at the forefront of pharmaceutical litigation for over 40 years. A nationally recognized law firm, Marc J. Bern & Partners LLP has been part of verdicts and settlements that have exceeded $ 3 Billion Dollars. Mr. Bern has been selected as one of “America’s Premier Lawyers” by Fortune Magazine and has been named one of the Top 100 Trial Lawyers by the National Trial Lawyers. He has been designated a New York Super Lawyer® every year since 2006. In 2007, he was honored to become a charter member of the Litigation Counsel of America. In addition, Mr. Bern has been selected as one of “America’s Premier Lawyers” by Fortune Magazine and has been named one of the Top 100 Trial Lawyers by the National Trial Lawyers.
With offices in five states Marc J. Bern & Partners LLP represents injury victims nationwide. Marc J. Bern & Partner LLP have both the fortitude and the resources to take on the well-funded pharmaceutical and medical device companies. To learn more about the Zostavax Litigation or to see if you may have a claim please contact Marc J. Bern & Partners LLP at 1-800-LAW-5432 or visit their website at www.bernllp.com.

To contact Mr. Bern directly call 1-516-361-4909

*Daniel Caudillo, et al. v. Merck & Co., Inc., et al. (Super. Ct. Alameda County, No. RG17857096.)

Marc J. Bern
Marc J. Bern & Partners LLP
(212) 702-5000
email us here

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release